SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

Share Price is delayed by 15 minutes
Get Live Data
443.00    10.00 (2.31%)
Bid:
440.00
Ask:
443.00
Spread: 3.00 (0.682%)
Market Cap: £218.72m
CLIG Live PriceLast checked at - London Stock Exchange

Intraday City Lon Inv Share Chart

Interim Management Statement

1 Oct 2012 07:00

RNS Number : 5299N
City of London Investment Group PLC
01 October 2012
 



1st October 2012

 

 

 

CITY OF LONDON INVESTMENT GROUP PLC

("City of London", "the Company" or "the Group")

 

INTERIM MANAGEMENT STATEMENT

AGM Trading Update

 

City of London (LSE: CLIG), a leading emerging markets asset management group, provides an Interim Management Statement for the period 31st May 2012 to 30th September 2012. City of London's Annual General Meeting is being held today.

 

The European debt crisis and slowing economic growth in China have continued to affect institutional appetite for risk assets, including emerging markets. Net client withdrawals since 31st May 2012 totalled $360 million. As noted in the Final Results announcement of 3rd September 2012, these were largely prompted by rebalancing of risk assets by asset allocators, although in some instances recent underperformance of the underlying NAVs and some discount widening was a factor. Approximately $120 million of net withdrawals is anticipated for the final quarter of the calendar year, based upon client instructions received.

 

Funds under Management

As at 30th September 2012, FuM were US$4.5 billion (£2.8 billion). This compares to US$4.5 billion (£2.9 billion) at the Company's year-end on 31st May 2012. In US dollar terms, allowing for client withdrawals, this represents marginal underperformance against the MSCI Emerging Markets Index, which increased by 12% over the same period.

 

Operations

The Group's income accrues at a weighted average rate of approximately 86 basis points, net of commissions. "Fixed" costs remain in line with budget at £0.9 million per month, and accordingly the current run-rate for operating profit, before profit-share at 30%, is approximately £1.2 million per month based upon current FuM and a US$/£ exchange rate of US$1.62 to £1. The Group estimates that post-tax profit for the first four months of the year will be approximately £2.2 million.

 

In a difficult marketing environment, we continue to raise profile for the Developed Closed-End Fund product and the Frontier Emerging Markets product. In addition, as the firm now has its own US$100 million Qualified Foreign Institutional Investor quota, the China A Share Closed-End Fund strategy is beginning to attract interest from prospects.

 

Dividends

The final dividend of 16 pence per share, subject to approval at today's AGM, will be paid on 19th October 2012, bringing the total dividend for the financial year 2011-12 to 24 pence. The Board expects to maintain the dividend during the current year. This may require a relaxation of the Group's 1.5x dividend cover policy, which the Group is well placed to accommodate in terms of both capital adequacy and liquidity.

 

Board composition

As previously announced, David Cardale will replace Andrew Davison as Chairman at the conclusion of the AGM. Lynn Ruddick will take over from David Cardale as the Senior Independent Director, and Allan Bufferd will become chairman of the Remuneration Committee.

 

Half year results for the six months to 30th November 2012 will be announced on 23rd January 2013.

 

For further information please visit www.citlon.co.uk or contact:

 

Doug Allison (Finance Director)

Simon Hudson / Kelsey Traynor

City of London Investment Group Plc

Tavistock Communications

Tel: +44 (0)20 7860 8347

Tel: +44 (0)20 7920 3150

Jonny Franklin-Adams

Martin Green

Singer Capital Markets Limited

Canaccord Genuity Limited

Financial Adviser & Joint Broker

Joint Broker

Tel: +44 (0)20 3205 7500

Tel: +44 (0)20 7523 8000

 

-ends-

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFMGFLVGRGZZM
Date   Source Headline
20th Apr 20267:00 amRNSTrading Update for the quarter to 31 March 2026
7th Apr 20262:44 pmRNSPDMR Shareholding
31st Mar 20261:56 pmRNSEBT Share Purchase
26th Mar 202612:09 pmRNSEBT Share Purchase
25th Mar 202611:33 amRNSPDMR Shareholding
24th Mar 20269:56 amRNSEBT Share Purchase
13th Mar 20263:05 pmRNSPDMR Shareholding
10th Mar 20264:07 pmRNSEBT Share Purchase
10th Mar 20264:07 pmRNSEBT Share Purchase
9th Mar 202612:35 pmRNSPDMR Shareholding
4th Mar 202612:48 pmRNSGrant of LTIP Award
24th Feb 20267:00 amRNSHalf Year Results and Dividend Declaration
13th Feb 202611:00 amRNSInvestor Presentation
21st Jan 20267:00 amRNSAppointment of Chief Executive Officer
19th Jan 20267:00 amRNSTrading Update - Six months to 31 December 2025
29th Oct 20253:15 pmRNSPDMR/PCA Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
29th Oct 20253:15 pmRNSPDMR Shareholding
27th Oct 20255:25 pmRNSResult of AGM
21st Oct 20255:00 pmRNSPDMR Shareholding
20th Oct 20257:00 amRNSTrading Update - Quarter to 30 September 2025
22nd Sep 20255:20 pmRNSCorrection: Final Results for year to 30 June 25
16th Sep 20257:00 amRNSFinal Results for the year to 30th June 2025
11th Sep 20257:00 amRNSInvestor Presentation via Investor Meet Company
5th Aug 20258:14 amRNSDirector Declaration
24th Jul 20257:00 amRNSPre-Close Trading Update
2nd Jul 20256:12 pmRNSBoard and Committee changes
1st Jul 202512:10 pmRNSDirector/PDMR Shareholding
17th Jun 20255:34 pmRNSDirector/PDMR Shareholding
13th Jun 20259:57 amRNSDirector/PDMR Shareholding
13th Jun 20259:47 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSDirectorate Change
22nd Apr 20257:00 amRNSFUNDS UNDER MANAGEMENT 31 MARCH 25, TRADING UPDATE
7th Apr 20257:00 amRNSAPPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
25th Feb 20257:00 amRNSHalf Year Results
20th Jan 20257:00 amRNSSIX MONTHS TO 31 DECEMBER 2024 TRADING UPDATE
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:27 pmRNSPDMR Dealing
29th Oct 20245:26 pmRNSPDMR Dealing
28th Oct 20245:57 pmRNSResult of AGM & Board change - Replacement
28th Oct 20244:14 pmRNSResult of AGM and Board and Committee change
21st Oct 20247:00 amRNSTRADING UPDATE - Quarter to 30 September 2024
17th Oct 20244:46 pmRNSHolding(s) in Company
16th Oct 20241:02 pmRNSHolding(s) in Company
11th Oct 20244:50 pmRNSHolding(s) in Company
24th Sep 20247:00 amRNSFINAL RESULTS FOR THE YEAR TO 30TH JUNE 2024
13th Sep 20242:54 pmRNSFull Year Results release date
25th Jul 20247:00 amRNSPRE-CLOSE TRADING UPDATE
23rd May 20244:32 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.